SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $18,342 | +25.9% | 19,106 | -1.6% | 0.00% | – |
Q1 2023 | $14,570 | +205.8% | 19,426 | +50.2% | 0.00% | – |
Q4 2022 | $4,765 | -87.1% | 12,931 | -84.8% | 0.00% | – |
Q3 2022 | $37,000 | -82.8% | 84,825 | -69.3% | 0.00% | – |
Q2 2022 | $215,000 | -32.8% | 276,163 | +11.3% | 0.00% | – |
Q1 2022 | $320,000 | -91.4% | 248,071 | -91.5% | 0.00% | -100.0% |
Q4 2021 | $3,705,000 | +326.8% | 2,916,719 | +632.0% | 0.00% | – |
Q3 2021 | $868,000 | -41.2% | 398,432 | +1.2% | 0.00% | – |
Q2 2021 | $1,476,000 | +5.1% | 393,644 | -8.7% | 0.00% | – |
Q1 2021 | $1,405,000 | -42.5% | 431,090 | -39.9% | 0.00% | -100.0% |
Q4 2020 | $2,445,000 | -17.5% | 717,003 | -1.3% | 0.00% | 0.0% |
Q3 2020 | $2,964,000 | +3.1% | 726,445 | -14.6% | 0.00% | 0.0% |
Q2 2020 | $2,874,000 | +11.4% | 850,303 | -23.2% | 0.00% | 0.0% |
Q1 2020 | $2,580,000 | -0.8% | 1,107,340 | +54.9% | 0.00% | 0.0% |
Q4 2019 | $2,601,000 | -25.3% | 714,721 | +70.4% | 0.00% | 0.0% |
Q3 2019 | $3,480,000 | -15.4% | 419,525 | -12.2% | 0.00% | 0.0% |
Q2 2019 | $4,115,000 | -44.1% | 477,963 | -30.5% | 0.00% | -50.0% |
Q1 2019 | $7,356,000 | +10.8% | 688,118 | -9.3% | 0.00% | 0.0% |
Q4 2018 | $6,638,000 | -35.0% | 758,663 | +24.9% | 0.00% | -33.3% |
Q3 2018 | $10,205,000 | -19.4% | 607,412 | +0.5% | 0.00% | -25.0% |
Q2 2018 | $12,668,000 | -59.5% | 604,401 | -68.9% | 0.00% | -50.0% |
Q1 2018 | $31,242,000 | -11.2% | 1,941,739 | +4.5% | 0.01% | 0.0% |
Q4 2017 | $35,202,000 | +37.8% | 1,857,580 | +2.3% | 0.01% | +33.3% |
Q3 2017 | $25,537,000 | +172.7% | 1,814,951 | +44.4% | 0.01% | +200.0% |
Q2 2017 | $9,364,000 | -11.5% | 1,256,958 | -22.8% | 0.00% | -33.3% |
Q1 2017 | $10,576,000 | +38.0% | 1,627,144 | -5.9% | 0.00% | +50.0% |
Q4 2016 | $7,663,000 | -0.2% | 1,729,833 | +5.2% | 0.00% | 0.0% |
Q3 2016 | $7,682,000 | -25.4% | 1,645,043 | +5.0% | 0.00% | -33.3% |
Q2 2016 | $10,296,000 | +11.0% | 1,567,195 | +7.5% | 0.00% | 0.0% |
Q1 2016 | $9,272,000 | +12.5% | 1,457,857 | +6.7% | 0.00% | 0.0% |
Q4 2015 | $8,239,000 | +1.9% | 1,366,410 | +1.0% | 0.00% | 0.0% |
Q3 2015 | $8,088,000 | -25.8% | 1,352,521 | -15.1% | 0.00% | 0.0% |
Q2 2015 | $10,902,000 | +2.4% | 1,593,884 | -9.1% | 0.00% | 0.0% |
Q1 2015 | $10,643,000 | +20.0% | 1,753,423 | +37.1% | 0.00% | 0.0% |
Q4 2014 | $8,866,000 | -14.8% | 1,279,393 | +0.1% | 0.00% | 0.0% |
Q3 2014 | $10,408,000 | +4.6% | 1,278,584 | +4.5% | 0.00% | 0.0% |
Q2 2014 | $9,946,000 | -8.4% | 1,223,321 | -11.7% | 0.00% | -25.0% |
Q1 2014 | $10,864,000 | -7.5% | 1,385,773 | +4.4% | 0.00% | 0.0% |
Q4 2013 | $11,749,000 | +10.3% | 1,327,560 | +4.4% | 0.00% | 0.0% |
Q3 2013 | $10,655,000 | +10.8% | 1,271,510 | -1.3% | 0.00% | 0.0% |
Q2 2013 | $9,613,000 | -70.3% | 1,288,602 | -55.5% | 0.00% | -71.4% |
Q4 2012 | $32,394,000 | +0.4% | 2,895,980 | +5.0% | 0.01% | +7.7% |
Q3 2012 | $32,268,000 | -51.8% | 2,757,987 | -35.9% | 0.01% | -55.2% |
Q2 2012 | $66,916,000 | +534.6% | 4,300,493 | +415.1% | 0.03% | +480.0% |
Q1 2012 | $10,545,000 | – | 834,951 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 6,963,756 | $145,960,000 | 9.42% |
Avoro Capital Advisors LLC | 3,419,818 | $71,679,000 | 2.76% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 300,000 | $6,285,000 | 2.41% |
Cormorant Asset Management, LP | 1,200,000 | $25,152,000 | 1.86% |
Sio Capital Management, LLC | 143,550 | $3,009,000 | 1.66% |
ASHFORD CAPITAL MANAGEMENT INC | 425,702 | $8,923,000 | 1.18% |
PURA VIDA INVESTMENTS, LLC | 130,700 | $2,739,000 | 1.10% |
Sonora Investment Management, LLC | 298,967 | $6,266,000 | 0.97% |
PURA VIDA INVESTMENTS, LLC | 100,000 | $2,096,000 | 0.84% |
J. Goldman & Co LP | 694,338 | $14,553,000 | 0.75% |